Limitations of Only Reporting the Odds Ratio in the Age of Precision Medicine: A Deterministic Simulation Study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review.Osong public health and research perspectives · 2024
   Article
2. Causes of Death in Neonates, Infants, Children, and Adolescents at the University Children's Clinical Hospital of Białystok Between 2018 and 2021.Medical science monitor : international medical journal of experimental and clinical research · 2023
   Observational
3. Commentary: Modeling mortality risk in patients with severe COVID-19 from Mexico.Frontiers in medicine · 2023
   Article
4. Estimating risk ratio from any standard epidemiological design by doubling the cases.BMC medical research methodology · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as